XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 4/7/2011 10:46:52 AM : Outperform Start Price: $10.15 XNPT Score: -41.17

biotech comeback us technicals

Featured Broker Partners


Advertisement